Entity Common Stock, Shares Outstanding of CAPRICOR THERAPEUTICS, INC. from Q2 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CAPRICOR THERAPEUTICS, INC. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q3 2025.
  • CAPRICOR THERAPEUTICS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 07 Nov 2025 was 45.7M shares, a 0.55% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 45.7M +249K +0.55% 07 Nov 2025 10-Q 10 Nov 2025
Q2 2025 45.7M +13.2M +40.5% 11 Aug 2025 10-Q 11 Aug 2025
Q1 2025 45.7M +14.3M +45.5% 24 Mar 2025 10-K 26 Mar 2025
Q3 2024 45.5M +14.7M +47.7% 13 Nov 2024 10-Q 14 Nov 2024
Q2 2024 32.5M +6.76M +26.2% 07 Aug 2024 10-Q 08 Aug 2024
Q1 2024 31.4M +6.14M +24.3% 07 Mar 2024 10-K 11 Mar 2024
Q3 2023 30.8M +5.55M +22% 13 Nov 2023 10-Q 14 Nov 2023
Q2 2023 25.8M +1.43M +5.88% 07 Aug 2023 10-Q 08 Aug 2023
Q1 2023 25.3M +957K +3.94% 16 Mar 2023 10-K 17 Mar 2023
Q3 2022 25.2M +1.09M +4.52% 09 Nov 2022 10-Q 10 Nov 2022
Q2 2022 24.3M +1.32M +5.75% 10 Aug 2022 10-Q 12 Aug 2022
Q1 2022 24.3M +1.5M +6.58% 09 Mar 2022 10-K 11 Mar 2022
Q3 2021 24.1M +3.7M +18.1% 09 Nov 2021 10-Q 12 Nov 2021
Q2 2021 23M +3.3M +16.7% 12 Aug 2021 10-Q 13 Aug 2021
Q1 2021 22.8M +13.9M +156% 12 Mar 2021 10-K 15 Mar 2021
Q3 2020 20.4M +16.2M +382% 12 Nov 2020 10-Q 13 Nov 2020
Q2 2020 19.7M +16M +428% 07 Aug 2020 10-Q 10 Aug 2020
Q1 2020 8.91M -24.8M -73.5% 27 Mar 2020 10-K 27 Mar 2020
Q3 2019 4.25M -26.8M -86.3% 08 Nov 2019 10-Q 08 Nov 2019
Q2 2019 3.74M -27M -87.9% 07 Aug 2019 10-Q 08 Aug 2019
Q1 2019 33.7M +5.95M +21.5% 28 Mar 2019 10-K 29 Mar 2019
Q3 2018 31.1M +5.36M +20.8% 14 Nov 2018 10-Q 14 Nov 2018
Q2 2018 30.7M +7.25M +30.9% 09 Aug 2018 10-Q 13 Aug 2018
Q1 2018 27.7M +6.31M +29.5% 20 Mar 2018 10-K 22 Mar 2018
Q3 2017 25.7M +4.31M +20.1% 10 Nov 2017 10-Q 14 Nov 2017
Q2 2017 23.5M +5.54M +30.9% 10 Aug 2017 10-Q 14 Aug 2017
Q1 2017 21.4M +3.45M +19.2% 14 Mar 2017 10-K 16 Mar 2017
Q3 2016 21.4M +5.14M +31.6% 11 Nov 2016 10-Q 14 Nov 2016
Q2 2016 18M +1.7M +10.5% 12 Aug 2016 10-Q 15 Aug 2016
Q1 2016 18M +1.73M +10.7% 29 Mar 2016 10-K 30 Mar 2016
Q3 2015 16.3M +4.55M +38.9% 12 Nov 2015 10-Q 13 Nov 2015
Q2 2015 16.3M +4.55M +38.9% 12 Aug 2015 10-Q 14 Aug 2015
Q1 2015 16.2M +4.53M +38.8% 13 Mar 2015 10-K 16 Mar 2015
Q3 2014 11.7M -31.8M -73.1% 12 Nov 2014 10-Q 14 Nov 2014
Q2 2014 11.7M -31.4M -72.8% 12 Aug 2014 10-Q 14 Aug 2014
Q1 2014 11.7M 26 Mar 2014 10-K 31 Mar 2014
Q3 2013 43.5M 12 Nov 2013 10-Q 14 Nov 2013
Q2 2013 43.1M 0 0% 19 Jun 2013 10-Q 21 Jun 2013
Q2 2012 43.1M +3.35M +8.45% 13 Aug 2012 10-Q/A 10 Sep 2012
Q1 2012 39.7M 29 Mar 2012 10-K 02 Apr 2012
Q3 2011 39.7M 11 Nov 2011 10-Q 14 Nov 2011
Q2 2011 39.7M 12 Aug 2011 10-Q 15 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.